Skip to Content
Merck
Search Within
Document Type

79-92-5

Applied Filters:
Keyword:'79-92-5'
Showing 1-30 of 289 results for "79-92-5" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
72 71 79 93 106 56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14 96 85 102 101 76 50 58 77 87 76 38
The Effective Use of Protein Kinase Inhibitors
72 71 79 93 106 56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14 96 85 102 101 76 50 58 77 87 76 38
Dental Application Brochure
Glycolic Acid 79-14-1 Magnesium Carbonate 23389-33-5 Potassium Sulfate PharmaGrade, EP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production 7778-80-5 Endodontics
Specialty Materials For Dental Applications Brochure
Methacryloyl chloride Precursor 920-46-7 Acrylic acid Precursor 79-10-7 Methacrylic acid Precursor 79-41-4 4 5 Inorganic Materials For Dental Applications The biocompatibility
SMC®Plate Washer Evaluation Kit
Plate Washer after Preventive Maintenance 1 2 3 4 5 6 7 8 9 10 11 12 Row Mean SD CV A 68 65 86 57 71 79 61 79 59 69 59 82 70 10 14
Spare parts for Mobius®Bioreactors (50 L, 200 L, 1000 L & 2000 L)
Cap Included —Not Shown 92 or 93 (depending on configuration) Nipple Only 52 86 1 5 76 50 97 96 87 94 95 76 2 84 78 79
Application Note - Assurance GDS - Alternative confirmation E. coli O157:H7 &Salmonella
IMS 1 mL vs. Reference Method CHROMID® Salmonella 79 58 5 16 84 78 RAPID’Salmonella 78 61 2 17 80 74 Salmonella ChromoSelect 81 45 18 14 99 92 All three plates 89 44 19 6
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
1:4 dil 64 79 139 94 110 89 67 99 79 114 1:8 dil 49 54 150 98 111 86 79 89 66 124 1:16 dil 93 79 120 118 89 95 109 84 98 93 Average
Testing Lab & Industrial Flyer
calc. to the dried substance) 77-09-8 Analytical 81460 Ponceau S for microscopy (Hist.) 6226-79-5 Analytical 429546 Propionaldehyde-2,4-dinitrophenylhydrazone analytical standard, for environmental
Product Information Sheet - M5639
, 208(1), 74-79 (1993). 3. John, R. A., in Photometric assays. Enzyme Assays A Practical Approach, Eisenthal, R., and Danson, M. J., eds., IRL Press (New York, NY: 1992), pp. 59-92. 4. Jacks
Data Sheet - R7898
least 10 isoforms of B-Raf have been identified in adult mouse tissues in the ranges of 69-72 kD and 79-99 kD.1 B-Raf is highly expressed in brain tissues2 and is activated by Ras3,4,. The 93-95 kD isoforms
Novabiochem Innovations 02/04
s. After this time, the crude reaction mixture was analyzed by HPLC. P S H 88 MeCN 160 4 92 5 0 99 DMF 160 2 6 90 0 99 MeCN 160 4 86
Quality Control Range Sheet- HST-111 and HST-211
1305 – 2711 pg/mL IFNγ Control 1 46 – 95 pg/mL IL-5 Control 1 19 – 39 pg/mL Control 2 196 – 407 pg/mL
User Guide-RAB0751
Serum 85 75-98 Plasma 79 73-94 Cell Culture Supernatants 84 74-94 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 83 97 92 Range (%) 75-91 89-103
User Guide-RAB1699
Cell Culture Supernatants 79 71-92 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 88 104 84 Range (%) 85-92 94-124 79-89 1:4 Average % of Expected
User Guide-RAB0675
Range (%) Serum 89 79-99 Plasma 91 88-97 Cell Culture Supernatants 79 69-88 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 98 92 88 Range (%) 90
Microwave accelerated Suzuki couplings employing a polymer-supported phosphine
acetonitrile. Fig. 6: 1H nmr spectrum of 1b. APCI: expected 253.3 found 254.3 P S H 88 MeCN 160 4 92 5 0 99 DMF 160 2 6 90 0 99 MeCN 160 4 86
User Guide-RAB0381
. Mean recoveries are as follows: Sample Type Average % Recovery Range (%) Serum 79 69-89 Plasma 79 65-92 Cell Culture Supernatants 108 94-117 Linearity Sample Type Serum Plasma Cell Culture
Data Sheet - SAB4200697
Tissue Res., 339, 463-79 (2010). 3. Ozburn AR., et al., Neuropsychopharmacology., 38, 2393-400 (2013). 4. Nagatsu T., et al., J. Biol. Chem., 239, 2910-17 (1964). 5. Grima B., et al., Nature
Data Sheet - S1444
Anti-Sprouty-2 (N-Terminal) is developed in rabbit using a synthetic peptide corresponding to amino acids 79-98 of mouse Sprouty 2 (Spry 2), conjugated to KLH via a C-terminal added lysine residue as immunogen
User Guide-RAB0252
Serum 83 78-102 Plasma 86 79-101 Cell Culture Supernatants 96 88-109 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 86 87 92 Range (%) 77-101 78-102
Quality Control Range Sheet- PCC-124 and PCC-224
TGFα Control 1 63 - 131 pg/mL IL-5 Control 1 74 - 155 pg/mL Control 2 425 - 882 pg/mL Control 2 579 - 1202 pg/mL
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
1028-1032 (1999). 5. Korenbaum, E., et al., Genomic organization and expression profile of the parvin family of focal adhesion protens in mice and humans., Gene, 279, 69-79 (2001). N ew P
FcFusionProteinSeparation
60 70 80 6. 14 0 6. 79 4 7. 47 8 7. 83 3 8. 71 8 9. 41 2 9. 92 9 10 .5 39 10 .8 13 11 .3 77 12 .0 42 12 .5
Impurities & Related Compounds: Reference Materials
-26-5 540-84-1 20535-83-5 149-57-5 345-92-6 874-43-1 51-78-5 123-42-2 103931-20-0 60-31-1 1466-82-6 530-75-6 121268-17-5 23828-92-4 37517-28-5 39831-55-5
Verfication summary-03-0202-00
HMN713786 3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% - 3 1:8 16.42 0.9 5% 131.35 6.9 5% 92% 3 1:16 8.17 0.4 5% 130.65 6.1 5% 92% 3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
Verfication summary-03-0202-00
HMN713786 3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% - 3 1:8 16.42 0.9 5% 131.35 6.9 5% 92% 3 1:16 8.17 0.4 5% 130.65 6.1 5% 92% 3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
Clarisolve®mPAA Polymer: A Stimulus-Responsive Flocculation Polymer for Cell Culture Clarification
.49 1 x 1.1m 2 1.1 mPAA 0.2% >60HX 55 95 -3.23 5 x 1.1m2 2.75 mPAA 0.2% >60HX >X0HC 71 79 -4.41 1 x 1.1m 2 1.1 mPAA 0.2% >60HX >X0SP 92 68 -4.03 1 x
CDK1/CyclinA2 active (C0244)
mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼79 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 78–106 nmole/min/mg (see Figure
Data Sheet - C7479
Eur. J. Biochem., 196, 79 (1991). 3. Heizmann, C.W., Gen. Physiol. Biophys., 11, 411 (1992). 4. Baimbridge, K.G., et al., Trends Neurosci., 15, 303 (1992). 5. Chard, P.S., et al., Proc.
Page 1 of 10